# Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients

> **NCT07701512** · PHASE2 · RECRUITING · sponsor: **Tanta University** · enrollment: 46 (estimated)

## Conditions studied

- Intracranial Hemorrhage

## Interventions

- **DRUG:** Febuxostat 40 mg
- **DRUG:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07701512
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-20
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-01-30
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701512, "Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*